Thirumalai Chemicals has received a show cause notice from the Office of the Assistant Commissioner, Central GST and Central Excise, Audit Commissionerate, Vadodara. The notice, issued under Section 74 of the CGST Act, 2017, follows an audit conducted under Section 65 of the same act. The authority alleges that the company failed to reverse input tax credit (ITC) on stock differences during the audit period spanning April 2020 to March 2024.

The total tax demand raised in the notice is ₹33.47 lakhs. The assessment of interest and penalty components remains unascertained at this stage. The company disclosed this development to stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

What the Numbers Show

The primary materiality of this regulatory action lies in its scale relative to the company's overall operations. With a total tax demand of ₹33.47 lakhs, the figure is explicitly described by the company as having a "very insignificant" financial implication. This suggests that even if the full amount were realized as a liability, it would not alter the company's near-term liquidity or balance sheet strength materially. The absence of quantified interest or penalty figures further limits the immediate downside risk visible in this disclosure.

Thirumalai Chemicals maintains that the demands are erroneous and not sustainable. The company intends to submit its response to the authority within the prescribed timelines. Management affirmed that any potential financial outcome from this proceeding will not have a material impact on the company's financial position.

Thirumalai Chemicals Limited shareholders approved the company’s audited financial statements for the financial year ended March 31, 2026, along with key governance resolutions at its 53rd Annual General Meeting. The meeting, held on August 07, 2026, via video conference, saw high participation from institutional investors and promoters, who overwhelmingly supported all five agenda items.

The proceedings were conducted in compliance with Section 108 of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Remote e-voting was open from August 04, 2026, to August 06, 2026, with additional voting available during the meeting. M/s. R M Mimani & Associates LLP served as the scrutinizer for the voting process.

Key Resolutions Passed

Shareholders voted on five ordinary and special resolutions. The promoter group, holding 44,766,433 shares, participated with 99.59% of their stake. Public institutions held 11,196,678 shares, while non-institutional public shareholders held 64,589,663 shares.

Ms. Ramya Bharathram, Managing Director and CFO, retired by rotation and offered herself for reappointment, securing strong support from both promoter and public shareholders. The appointment of M/s. PKF Sridharan & Santhanam LLP as statutory auditor passed with 98.29% support, though it faced slightly higher opposition from public institutions compared to other resolutions.

Strategic Outlook and Operational Challenges

In his address, Chairman R. Parthasarathy outlined significant macroeconomic headwinds impacting the chemical sector over the past two years. He cited five major shocks: the Ukraine war, slowing Chinese consumption, post-pandemic supply chain inflation, recent US tariff hikes from near 3% to over 50%, and conflicts in Gaza and Iran driving up logistics and feedstock costs.

These disruptions forced the company to switch from nearly 100% domestic feedstock supply to 100% imports almost overnight. This shift impacted working capital needs and manufacturing stability for its liquid raw material requirements of 150,000–200,000 tons per year. Consequently, the company moved from a zero-debt position in 2021-23 to a high-debt scenario with elevated finance costs.

What the Numbers Show

Despite operational pressures, the company’s Gujarat subsidiary plant has stabilized, operating at 90–95% capacity utilization. The US project, though delayed by global events, is now complete with stage-wise startup in progress. The US subsidiary benefits from low butane prices compared to Asia and Europe, positioning it advantageously in the largest global market for food ingredients. Management indicated that the US subsidiary aims to become independent of India funding support by ramping up production in 2027 and 2028, thereby reducing group debt levels.

The Malaysian subsidiary has mothballed its front-end Maleic plant to reduce costs but continues operations in derivatives. Management emphasized that debt reduction remains a priority, supported by improved working capital management through better-structured credit lines from suppliers and bankers.